| tau pathology |
phenotype |
4 |
4 |
tau, tauopathy |
| tau phosphorylation |
drug |
3 |
2 |
AT8, PHF1, p-tau |
| tau protein |
drug |
4 |
4 |
Tau, phosphorylated Tau, tau |
| taurine |
drug |
4 |
2 |
GABAA receptor agonist taurine, taurine |
| TBP |
gene |
2 |
1 |
TATA-binding protein |
| TBR2 |
gene |
3 |
2 |
EOMES |
| T cells |
phenotype |
5 |
3 |
CD3+CD8+ T cells, T lymphocytes |
| TCF7L2 |
gene |
15 |
7 |
transcription factor 4 |
| TCGA |
cohort |
7 |
1 |
The Cancer Genome Atlas |
| tCr |
drug |
5 |
1 |
total creatine |
| TD |
phenotype |
2 |
1 |
Tourette Disorder, Tourette disorder, tardive dyskinesia, typical development |
| tDCS |
drug |
2 |
2 |
transcranial direct current stimulation |
| teachers |
cohort |
6 |
2 |
|
| teens |
cohort |
8 |
4 |
adolescents, teenage years, youth |
| telomere length |
phenotype |
4 |
1 |
telomere |
| Telomeres |
drug |
2 |
1 |
telomere reserves |
| temperament |
phenotype |
9 |
5 |
child’s temperament, component of temperament |
| temper tantrums |
phenotype |
2 |
1 |
|
| teratoma |
phenotype |
3 |
— |
teratomas |
| TERT |
gene |
6 |
3 |
Tert, human TERT, telomerase, telomerase reverse transcriptase |
